You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Exemestane

Showing 1 - 25 of 366
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ive Alzheimer's Medicines- Anastrozole vs Exemestane/Letrozole

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 1, 2022

Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for

Recruiting
  • Breast Cancer
  • Tianjin, Tianjin, China
    Jie Ge
Aug 20, 2023

Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Phoenix, Arizona
  • +3 more
Jan 30, 2023

Metastatic or Locally-advanced Unresectable Breast Cancer Trial in New York (BYL719, Letrozole, Exemestane)

Completed
  • Metastatic or Locally-advanced Unresectable Breast Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 1, 2022

Breast Tumors Trial (Chidamide combined with exemestane (+/- goserelin), Chemotherapy with docetaxel plus epirubicin or change

Not yet recruiting
  • Breast Neoplasms
  • Chidamide combined with exemestane (+/- goserelin)
  • Chemotherapy with docetaxel plus epirubicin or change of chemotherapy regimen (at the discretion of the clinician)
  • (no location specified)
Feb 15, 2022

Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)

Completed
  • Breast Cancer
  • Estrogen Receptor Positive Breast Cancer
  • Denver, Colorado
  • +2 more
Dec 14, 2021

Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)

Completed
  • Advanced Breast Cancer
  • Guangzhou, Guangdong, China
  • +14 more
Jun 17, 2022

Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in Aurora (Exemestane, Exemestane and tamoxifen)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Exemestane
  • Exemestane and tamoxifen
  • Aurora, Colorado
    University of Colorado Cancer Center
Feb 22, 2022

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • (no location specified)
Oct 13, 2023

Breast Tumor Female Trial in Beijing (CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou))

Recruiting
  • Breast Neoplasm Female
  • CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
  • Beijing, Beijing, China
  • +1 more
Jul 31, 2023

Breast Cancer Trial in Chikusa-ku, Chuo-ku (KHK2375, Exemestane)

Completed
  • Breast Cancer
  • Chikusa-ku, Aichi, Japan
  • +2 more
Jun 15, 2022

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

HR Positive HER2 Negative Advanced Breast Cancer Trial in Tianjin (Chidamide)

Recruiting
  • HR Positive HER2 Negative Advanced Breast Cancer
  • Tianjin, China
    天津市肿瘤医院
May 26, 2023

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)

Completed
Has Results
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Yuma, Arizona
  • +93 more
Nov 4, 2022

Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Italy, United

Active, not recruiting
  • Stage 0 Breast Cancer AJCC v6 and v7
  • +6 more
  • Exemestane
  • +6 more
  • Tampa, Florida
  • +4 more
Dec 15, 2021

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • New York, New York
    Pfizer New York
Oct 11, 2023

Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Miami, Florida
    University of Miami
Apr 12, 2023

Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Mar 7, 2023

Breast Tumors Trial in Worldwide (Xentuzumab, Placebo, Everolimus)

Completed
Has Results
  • Breast Neoplasms
  • Chandler, Arizona
  • +53 more
Dec 13, 2022

Advanced Breast Cancer Trial in Beijing (Entinostat, Placebo, Exemestane)

Active, not recruiting
  • Advanced Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy Medical Sciences
Jul 7, 2021

Tumors Trial in Worldwide (Everolimus, Exemestane, BI 836845)

Completed
  • Neoplasms
  • Graz, Austria
  • +37 more
Feb 2, 2022

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023